API Production

GMP Manufacturing Services

Regis Technologies partners with our customers to produce Active Pharmaceutical Ingredients (APIs) and intermediates. We have been meeting customers investigational and commercial API needs for over 25 years. Our services can advance projects from pre-clinical to commercial, including initial process development, pre-clinical supply, scale-up, validation and on-going commercial manufacturing.

Learn more about our GMP Manufacturing Services.

Analytical Development

Pharmaceutical Services

Regis is a well-known for our expertise in Analytical Development, Chromatography, API Development and Manufacturing. We leverage these strengths setting Regis apart with the applied spectroscopy and chromatography techniques necessary for developing an IND into an NDA. Regis is leader in chiral and achiral HPLC, UHPLC, GC, NMR, ICP-MS, LC-MS, and GC-MS. Pharma Services include method development, method validation, API release, impurity services, reference standard characterization, solid state chemistry, and ICH compliant stability storage, methods and testing.

All of Regis` Pharma Services are all performed on site in a cGMP environment.

Learn more about our Pharma Services.

Proprietary Columns and Reagents

Chromatography Products

Regis Technologies is a leading manufacturer of chromatography products, especially those with a chiral emphasis. We offer our proprietary Chiral Stationary Phases and HPLC columns as well as IAM Drug Discovery Columns, RAM Direct Injection Columns, Ion Pairing Reagents and Buffers, and GC Derivatization Reagents.

Learn more about our Chromatography Products.

Organic Chemicals

Fine Chemicals Manufacturer

Regis Technologies has manufactured a small portfolio of high purity fine organic chemicals according to controlled manufacturing procedures for over 60 years.

Learn more about our Fine Chemicals.

Heritage

Founded in 1956

Located in Morton Grove, a suburb of Chicago, Regis Technologies, Inc., is a privately held company founded in 1956 and operated by the Glunz family. Regis continually updates and maintains a modern 36,000 square foot facility. Regis became a fully compliant GMP organization in 1993. By 2002, Regis expanded and improved every lab and manufacturing area. This included a new production facility with six dedicated reactor suites, individual kilo lab suites, an expanded quality control department and the installation of a cryogenic reactor. In 2009, we built a multi-million dollar Quality Control Laboratory and dedicated NMR room. In 2016 we built a new HPAPI production facility, and in 2020, we added state-of-the-art laboratories to advance our capabilities in Analytical Development, Solid-State Chemistry, and Process Development.

Regis Custom Pharma & Ground Zero Pharmaceuticals - Process Development Strategies Webinar - Video